scholarly journals Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2–5 and on dialysis

2017 ◽  
Vol 32 (7) ◽  
pp. 1098-1113 ◽  
Author(s):  
Rukshana Shroff ◽  
Mandy Wan ◽  
Evi V. Nagler ◽  
Sevcan Bakkaloğlu ◽  
Dagmar-C. Fischer ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Clinical Practice ◽  
Kidney Disease ◽  
Practice Recommendations ◽  
Disease Stages

scholarly journals Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2–5 and on dialysis

2017 ◽  
Vol 32 (7) ◽  
pp. 1114-1127 ◽  
Author(s):  
Rukshana Shroff ◽  
Mandy Wan ◽  
Evi V. Nagler ◽  
Sevcan Bakkaloğlu ◽  
Mario Cozzolino ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Clinical Practice ◽  
Kidney Disease ◽  
Active Vitamin ◽  
Practice Recommendations ◽  
Active Vitamin D ◽  
Vitamin D Analogues ◽  
Disease Stages

scholarly journals Delivery of a nutritional prescription by enteral tube feeding in children with chronic kidney disease stages 2–5 and on dialysis—clinical practice recommendations from the Pediatric Renal Nutrition Taskforce

2020 ◽  
Vol 36 (1) ◽  
pp. 187-204
Author(s):  
Lesley Rees ◽  
◽  
Vanessa Shaw ◽  
Leila Qizalbash ◽  
Caroline Anderson ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Clinical Practice ◽  
Kidney Disease ◽  
Growth Parameters ◽  
Tube Feeding ◽  
Low Grade ◽  
Enteral Tube Feeding ◽  
Practice Recommendations ◽  
The Individual ◽  
Disease Stages

AbstractThe nutritional prescription (whether in the form of food or liquid formulas) may be taken orally when a child has the capacity for spontaneous intake by mouth, but may need to be administered partially or completely by nasogastric tube or gastrostomy device (“enteral tube feeding”). The relative use of each of these methods varies both within and between countries. The Pediatric Renal Nutrition Taskforce (PRNT), an international team of pediatric renal dietitians and pediatric nephrologists, has developed clinical practice recommendations (CPRs) based on evidence where available, or on the expert opinion of the Taskforce members, using a Delphi process to seek consensus from the wider community of experts in the field. We present CPRs for delivery of the nutritional prescription via enteral tube feeding to children with chronic kidney disease stages 2–5 and on dialysis. We address the types of enteral feeding tubes, when they should be used, placement techniques, recommendations and contraindications for their use, and evidence for their effects on growth parameters. Statements with a low grade of evidence, or based on opinion, must be considered and adapted for the individual patient by the treating physician and dietitian according to their clinical judgement. Research recommendations have been suggested. The CPRs will be regularly audited and updated by the PRNT.

scholarly journals Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5)

2012 ◽  
Vol 28 (9) ◽  
pp. 1739-1748 ◽  
Author(s):  
Aleksandra M. Zurowska ◽  
◽  
Michel Fischbach ◽  
Alan R. Watson ◽  
Alberto Edefonti ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Clinical Practice ◽  
Kidney Disease ◽  
Practice Recommendations

Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4

Nephrology ◽  
2007 ◽  
Vol 0 (0) ◽  
pp. 070918212946008-??? ◽  
Author(s):  
ARISTEIDIS STAVROULOPOULOS ◽  
CHRISTINE J PORTER ◽  
SIMON D ROE ◽  
DAVID J HOSKING ◽  
MICHAEL JD CASSIDY
Keyword(s):  
Bone Mineral Density ◽  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Parathyroid Hormone ◽  
Kidney Disease ◽  
Bone Mineral ◽  
Vitamin D Status ◽  
Mineral Density ◽  
Hormone Levels ◽  
Disease Stages

scholarly journals Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease

2019 ◽  
Vol 15 (9) ◽  
pp. 577-589 ◽  
Author(s):  
Jens Drube ◽  
◽  
Mandy Wan ◽  
Marjolein Bonthuis ◽  
Elke Wühl ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Growth Hormone ◽  
Clinical Practice ◽  
Kidney Disease ◽  
Growth Hormone Treatment ◽  
Hormone Treatment ◽  
Practice Recommendations

scholarly journals Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice

Nutrients ◽  
2019 ◽  
Vol 11 (8) ◽  
pp. 1918 ◽  
Author(s):  
Carlo Alfieri ◽  
Oksana Ruzhytska ◽  
Simone Vettoretti ◽  
Lara Caldiroli ◽  
Mario Cozzolino ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Clinical Practice ◽  
Kidney Disease ◽  
Experimental Evidence ◽  
Hypovitaminosis D ◽  
Clinical Impact ◽  
Ckd Progression ◽  
Mineral Bone Disorder ◽  
Bone Disorder

Native hypovitaminosis D (n-hVITD) is frequently found from the early stages of chronic kidney disease (CKD) and its prevalence increases with CKD progression. Even if the implications of n-hVITD in chronic kidney disease-mineral bone disorder (CKD-MBD) have been extensively characterized in the literature, there is a lot of debate nowadays about the so called “unconventional effects” of native vitamin D (25(OH)VitD) supplementation in CKD patients. In this review, highlights of the dimension of the problem of n-hVITD in CKD stages 2–5 ND patients will be presented. In addition, it will focus on the “unconventional effects” of 25(OH)VitD supplementation, the clinical impact of n-hVITD and the most significant interventional studies regarding 25(OH)VitD supplementation in CKD stages 2–5 ND.

Sign in / Sign up

Export Citation Format

Share Document